🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an uncontrolled, open-label, non-randomized phase I / pharmacokinet...
Status
Completed
Location
Multiple Locations
Start Date
2010-11-19
Trial ID
NCT01179295
Treatments Being Tested
The PI3K (phosphoinositol 3-Kinase) inhibitor Copanlisib and the MEK (mitog...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01392521
Treatments Being Tested
This is a study to investigate the potential clinical benefit of refametini...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-27
Trial ID
NCT01915602
Treatments Being Tested
This is a study to investigate the potential clinical benefit of refametini...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-16
Trial ID
NCT01915589
Treatments Being Tested
Open-label, uncontrolled, Phase I/II study to evaluate safety and efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-01
Trial ID
NCT01251640
Treatments Being Tested
This is an open-label, uncontrolled, Phase Ib study designed to evaluate th...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-05
Trial ID
NCT01764828
Treatments Being Tested
The purpose of this study is to see if there is a difference between the wa...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01925638
Treatments Being Tested
Phase I: Determine the maximum tolerated dose of combination of Regorafenib...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06-23
Trial ID
NCT02168777
Treatments Being Tested
This study investigates the safety and efficacy of the combination therapy ...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01204177
Treatments Being Tested